Ignite Creation Date:
2024-05-06 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02756624
Status:
COMPLETED
Last Update Posted:
2017-09-11
First Post:
2016-04-20
Brief Title:
A Multi-Center Vehicle-Controlled Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
Sponsor:
Nicox Ophthalmics Inc
Organization:
Nicox Ophthalmics Inc
Study Overview
Official Title:
A Multi-Center Double-Masked Randomized Vehicle-Controlled Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is study is evaluating the safety and tolerability of AC-170 Ophthalmic Solution
Detailed Description:
Central Cornea Endothelial Cell Counts will be done on a subset of approximately 150 subjects to complete 100 subjects as part of the safety measures
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None